“Serum Troponin-I Levels Facilitate Early Prediction of Cardiac Toxicity among High-Risk Patients Under Chemotherapy with Doxorubicin”, Mugda Med. Coll. J., vol. 9, no. 1, pp. 43–47, Jun. 2026, doi: 10.3329/mumcj.v9i1.90817.